FECAL CALPROTECTIN AS A SURROGATE MARKER OF CLINICAL REMISSION, CLINICAL RESPONSE, ENDOSCOPIC IMPROVEMENT, AND HISTO-ENDOSCOPIC MUCOSAL HEALING: UNIFI INDUCTION STUDY
Brian G. Feagan 1
Reena Khanna 2
Colleen W. Marano 3
Hongyan Zhang 3
Bruce E. Sands 4
1 Robarts Research Institute, London, Canada
2 University of Western Ontario, London, Canada
3 Janssen Research & Development, LLC, Spring House, United States
4 Icahn School of Medicine at Mount Sinai, New York, United States
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]